BNP Paribas Financial Markets’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $327M | Buy |
665,128
+77,645
| +13% | +$42.1M | 0.16% | 123 |
|
|
2025
Q4 | $340M | Buy |
587,483
+189,763
| +48% | +$107M | 0.15% | 118 |
|
|
2025
Q3 | $193M | Sell |
397,720
-754,616
| -65% | -$351M | 0.1% | 186 |
|
|
2025
Q2 | $467M | Sell |
1,152,336
-65,279
| -5% | -$27.3M | 0.27% | 71 |
|
|
2025
Q1 | $606M | Buy |
1,217,615
+171,104
| +16% | +$92.7M | 0.36% | 52 |
|
|
2024
Q4 | $544M | Buy |
1,046,511
+104,736
| +11% | +$57.6M | 0.31% | 50 |
|
|
2024
Q3 | $583M | Sell |
941,775
-207,570
| -18% | -$123M | 0.39% | 41 |
|
|
2024
Q2 | $636M | Buy |
1,149,345
+321,984
| +39% | +$184M | 0.52% | 27 |
|
|
2024
Q1 | $481M | Buy |
827,361
+328,901
| +66% | +$185M | 0.42% | 38 |
|
|
2023
Q4 | $265M | Buy |
498,460
+16,223
| +3% | +$7.85M | 0.3% | 59 |
|
|
2023
Q3 | $244M | Sell |
482,237
-291,439
| -38% | -$155M | 0.31% | 49 |
|
|
2023
Q2 | $404M | Sell |
773,676
-122,867
| -14% | -$66.3M | 0.5% | 26 |
|
|
2023
Q1 | $517M | Buy |
896,543
+175,052
| +24% | +$98.7M | 0.72% | 18 |
|
|
2022
Q4 | $397M | Sell |
721,491
-270,820
| -27% | -$144M | 0.61% | 16 |
|
|
2022
Q3 | $503M | Buy |
992,311
+817,736
| +468% | +$458M | 0.81% | 12 |
|
|
2022
Q2 | $94.8M | Buy |
174,575
+75,558
| +76% | +$41.6M | 0.15% | 150 |
|
|
2022
Q1 | $58.5M | Sell |
99,017
-41,836
| -30% | -$24M | 0.08% | 253 |
|
|
2021
Q4 | $94M | Sell |
140,853
-37,030
| -21% | -$23.1M | 0.13% | 157 |
|
|
2021
Q3 | $102M | Sell |
177,883
-151,444
| -46% | -$83.1M | 0.14% | 162 |
|
|
2021
Q2 | $166M | Buy |
329,327
+276,977
| +529% | +$131M | 0.22% | 100 |
|
|
2021
Q1 | $23.9M | Buy |
52,350
+10,575
| +25% | +$5.05M | 0.04% | 487 |
|
|
2020
Q4 | $19.5M | Sell |
41,775
-188,734
| -82% | -$88.5M | 0.04% | 505 |
|
|
2020
Q3 | $102M | Buy |
230,509
+106,732
| +86% | +$44.1M | 0.15% | 132 |
|
|
2020
Q2 | $44.8M | Buy |
123,777
+31,142
| +34% | +$10.4M | 0.08% | 229 |
|
|
2020
Q1 | $26.3M | Sell |
92,635
-39,033
| -30% | -$12.3M | 0.05% | 319 |
|
|
2019
Q4 | $42.8M | Buy |
131,668
+50,333
| +62% | +$15.3M | 0.08% | 263 |
|
|
2019
Q3 | $23.7M | Sell |
81,335
-22,448
| -22% | -$6.43M | 0.04% | 439 |
|
|
2019
Q2 | $30.5M | Buy |
103,783
+19,164
| +23% | +$5.28M | 0.06% | 337 |
|
|
2019
Q1 | $23.2M | Buy |
84,619
+28,406
| +51% | +$7.07M | 0.05% | 382 |
|
|
2018
Q4 | $12.6M | Sell |
56,213
-110,827
| -66% | -$26M | 0.03% | 560 |
|
|
2018
Q3 | $40.8M | Sell |
167,040
-298,882
| -64% | -$68.8M | 0.06% | 300 |
|
|
2018
Q2 | $96.5M | Buy |
465,922
+301,827
| +184% | +$64.1M | 0.16% | 126 |
|
|
2018
Q1 | $33.9M | Buy |
164,095
+26,065
| +19% | +$5.47M | 0.06% | 290 |
|
|
2017
Q4 | $26.2M | Sell |
138,030
-275,429
| -67% | -$52.8M | 0.05% | 361 |
|
|
2017
Q3 | $78.2M | Buy |
413,459
+234,401
| +131% | +$42.5M | 0.19% | 100 |
|
|
2017
Q2 | $31.2M | Sell |
179,058
-115,788
| -39% | -$19.4M | 0.09% | 215 |
|
|
2017
Q1 | $45.3M | Buy |
294,846
+258,189
| +704% | +$39.5M | 0.12% | 168 |
|
|
2016
Q4 | $5.17M | Buy |
36,657
+15,854
| +76% | +$2.34M | 0.02% | 550 |
|
|
2016
Q3 | $3.31M | Sell |
20,803
-14,412
| -41% | -$2.22M | 0.01% | 563 |
|
|
2016
Q2 | $5.2M | Sell |
35,215
-146,311
| -81% | -$21.6M | 0.02% | 458 |
|
|
2016
Q1 | $25.7M | Buy |
181,526
+88,973
| +96% | +$11.9M | 0.11% | 152 |
|
|
2015
Q4 | $13.1M | Sell |
92,553
-268,377
| -74% | -$35.8M | 0.03% | 394 |
|
|
2015
Q3 | $44.1M | Buy |
360,930
+223,151
| +162% | +$29.1M | 0.11% | 117 |
|
|
2015
Q2 | $17.9M | Sell |
137,779
-78,949
| -36% | -$10.3M | 0.05% | 218 |
|
|
2015
Q1 | $29.1M | Buy |
216,728
+32,835
| +18% | +$4.23M | 0.08% | 155 |
|
|
2014
Q4 | $23M | Buy |
183,893
+13,038
| +8% | +$1.59M | 0.08% | 209 |
|
|
2014
Q3 | $20.8M | Buy |
170,855
+33,409
| +24% | +$4.06M | 0.02% | 318 |
|
|
2014
Q2 | $16.2M | Sell |
137,446
-27,524
| -17% | -$3.24M | 0.02% | 292 |
|
|
2014
Q1 | $18.8M | Sell |
164,970
-20,841
| -11% | -$2.48M | 0.01% | 292 |
|
|
2013
Q4 | $20.7M | Sell |
185,811
-13,501
| -7% | -$1.34M | 0.02% | 286 |
|
|
2013
Q3 | $18.4M | Buy |
199,312
+190,499
| +2,162% | +$17.2M | 0.01% | 341 |
|
|
2013
Q2 | $746K | Buy |
+8,813
| New | +$734K | ﹤0.01% | 1222 |
|
Other funds holding TMO
VCM
BNP Paribas Financial Markets's TMO Position: Q1 2026 in Review
BNP Paribas Financial Markets increased its Thermo Fisher Scientific (TMO) stake by 13% in Q1 2026, buying an estimated $42.1M and bringing the position to 665,128 shares worth $327M. The position accounts for 0.16% of the portfolio, ranked #123.
BNP Paribas Financial Markets first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $636M in Q2 2024. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- BNP Paribas Financial Markets held 665,128 shares of Thermo Fisher Scientific worth $327M as of Q1 2026.
- BNP Paribas Financial Markets bought 77,645 Thermo Fisher Scientific shares in Q1 2026, an estimated $42.1M.
- Thermo Fisher Scientific made up 0.16% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #123 holding.
- BNP Paribas Financial Markets first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- BNP Paribas Financial Markets's Thermo Fisher Scientific position peaked at $636M in Q2 2024.
- 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.